Cargando…

Genome-wide CRISPR screens of oral squamous cell carcinoma reveal fitness genes in the Hippo pathway

New therapeutic targets for oral squamous cell carcinoma (OSCC) are urgently needed. We conducted genome-wide CRISPR-Cas9 screens in 21 OSCC cell lines, primarily derived from Asians, to identify genetic vulnerabilities that can be explored as therapeutic targets. We identify known and novel fitness...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chai, Annie Wai Yeeng, Yee, Pei San, Price, Stacey, Yee, Shi Mun, Lee, Hui Mei, Tiong, Vivian KH, Gonçalves, Emanuel, Behan, Fiona M, Bateson, Jessica, Gilbert, James, Tan, Aik Choon, McDermott, Ultan, Garnett, Mathew J, Cheong, Sok Ching
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	eLife Sciences Publications, Ltd 2020
Materias:	Cancer Biology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7591259/ https://www.ncbi.nlm.nih.gov/pubmed/32990596 http://dx.doi.org/10.7554/eLife.57761

Ejemplares similares

Uncovering drug repurposing candidates for head and neck cancers: insights from systematic pharmacogenomics data analysis
por: Chai, Annie Wai Yeeng, et al.
Publicado: (2021)

Rational Combinations of Targeted Therapy and Immune Checkpoint Inhibitors in Head and Neck Cancers
por: Chai, Annie Wai Yeeng, et al.
Publicado: (2022)

The evolving role of cancer cell line-based screens to define the impact of cancer genomes on drug response()
por: Garnett, Mathew J, et al.
Publicado: (2014)

Functional linkage of gene fusions to cancer cell fitness assessed by pharmacological and CRISPR-Cas9 screening
por: Picco, Gabriele, et al.
Publicado: (2019)

High-throughput RNAi screen for essential genes and drug synergistic combinations in colorectal cancer
por: Williams, Steven P., et al.
Publicado: (2017)

Corrigendum: High-throughput RNAi screen for essential genes and drug synergistic combinations in colorectal cancer
por: Williams, Steven P., et al.
Publicado: (2018)

Targeting the RB-E2F pathway in breast cancer
por: Johnson, Jackie, et al.
Publicado: (2016)

JACKS: joint analysis of CRISPR/Cas9 knockout screens
por: Allen, Felicity, et al.
Publicado: (2019)

Identification of differential PI3K pathway target dependencies in T-cell acute lymphoblastic leukemia through a large cancer cell panel screen
por: Lynch, James T., et al.
Publicado: (2016)

Structural rearrangements generate cell-specific, gene-independent CRISPR-Cas9 loss of fitness effects
por: Gonçalves, Emanuel, et al.
Publicado: (2019)

Machine Learning Prediction of Cancer Cell Sensitivity to Drugs Based on Genomic and Chemical Properties
por: Menden, Michael P., et al.
Publicado: (2013)

Minimal genome-wide human CRISPR-Cas9 library
por: Gonçalves, Emanuel, et al.
Publicado: (2021)

Genome-wide CRISPR/Cas9 deletion screen defines mitochondrial gene essentiality and identifies routes for tumour cell viability in hypoxia
por: Thomas, Luke W., et al.
Publicado: (2021)

Logic models to predict continuous outputs based on binary inputs with an application to personalized cancer therapy
por: Knijnenburg, Theo A., et al.
Publicado: (2016)

Identification of Intrinsic Drug Resistance and Its Biomarkers in High-Throughput Pharmacogenomic and CRISPR Screens
por: Ayestaran, Iñigo, et al.
Publicado: (2020)

The germline genetic component of drug sensitivity in cancer cell lines
por: Menden, Michael P., et al.
Publicado: (2018)

DeSigN: connecting gene expression with therapeutics for drug repurposing and development
por: Lee, Bernard Kok Bang, et al.
Publicado: (2017)

Unsupervised correction of gene-independent cell responses to CRISPR-Cas9 targeting
por: Iorio, Francesco, et al.
Publicado: (2018)

RAD50 Loss of Function Variants in the Zinc Hook Domain Associated with Higher Risk of Familial Esophageal Squamous Cell Carcinoma
por: Ko, Josephine Mun Yee, et al.
Publicado: (2021)

Functional Genomic Identification of Predictors of Sensitivity and Mechanisms of Resistance to Multivalent Second-Generation TRAIL-R2 Agonists
por: Grinkevitch, Vera, et al.
Publicado: (2022)

BRAF/NRAS wild-type melanoma, NF1 status and sensitivity to trametinib
por: Ranzani, Marco, et al.
Publicado: (2015)

Combinations of PARP Inhibitors with Temozolomide Drive PARP1 Trapping and Apoptosis in Ewing’s Sarcoma
por: Gill, Sonja J., et al.
Publicado: (2015)

Combinatorial CRISPR screen identifies fitness effects of gene paralogues
por: Thompson, Nicola A., et al.
Publicado: (2021)

FANCD2 limits replication stress and genome instability in cells lacking BRCA2
por: Michl, Johanna, et al.
Publicado: (2016)

The Roles of YAP/TAZ and the Hippo Pathway in Healthy and Diseased Skin
por: Rognoni, Emanuel, et al.
Publicado: (2019)

Autopalmitoylation of TEAD Proteins Regulates Transcriptional Output of Hippo Pathway
por: Chan, PuiYee, et al.
Publicado: (2016)

Assembly and activation of the Hippo signalome by FAT1 tumor suppressor
por: Martin, Daniel, et al.
Publicado: (2018)

The CAF-1 complex couples Hippo pathway target gene expression and DNA replication
por: Yee, William B., et al.
Publicado: (2019)

Drug mechanism‐of‐action discovery through the integration of pharmacological and CRISPR screens
por: Gonçalves, Emanuel, et al.
Publicado: (2020)

CRISPR Loss-of-Function Screen Identifies the Hippo Signaling Pathway as the Mediator of Regorafenib Efficacy in Hepatocellular Carcinoma
por: Suemura, Shigeki, et al.
Publicado: (2019)

HippoDraw
por: Gravina, M F, et al.
Publicado: (1992)

Hippo Pathway in Cancer, towards the Realization of Hippo-Targeted Therapy
por: Hata, Yutaka
Publicado: (2018)

Imipridone ONC212 activates orphan G protein-coupled receptor GPR132 and integrated stress response in acute myeloid leukemia
por: Nii, Takenobu, et al.
Publicado: (2019)

Agreement between two large pan-cancer CRISPR-Cas9 gene dependency data sets
por: Dempster, Joshua M., et al.
Publicado: (2019)

The Hippo pathway mediates Semaphorin signaling
por: Meng, Zhipeng, et al.
Publicado: (2022)

Project Score database: a resource for investigating cancer cell dependencies and prioritizing therapeutic targets
por: Dwane, Lisa, et al.
Publicado: (2020)

Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms
por: Dobrokhotov, Oleg, et al.
Publicado: (2018)

The Hippo signaling pathway in gastric cancer: Targeting Hippo for GC treatment
por: Cao, Zhifa, et al.
Publicado: (2023)

Dishevelling Wnt and Hippo
por: Kim, Nam Hee, et al.
Publicado: (2018)

Hippo Signaling in the Endometrium
por: Moon, Sohyeon, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_kde2pdchb4i4m459r6cm1nlbct